Market Performance - The Sci-Tech Innovation Board (STAR Market) index rose by 0.19%, closing at 1007.53 points, with a total trading volume of 3.622 billion shares and a turnover of 124.775 billion yuan, resulting in an average turnover rate of 2.02% [1] - Among the tradable stocks on the STAR Market, 324 stocks closed higher, with 9 stocks experiencing a rise of over 10%, including Electric Wind Power, Fumiao Technology, and Shangwei New Materials, which hit the daily limit [1] - The distribution of turnover rates shows that 2 stocks had turnover rates exceeding 20%, 24 stocks had rates between 10% and 20%, and 59 stocks had rates between 5% and 10% [1] High Turnover Stocks - The stock with the highest turnover rate was Xinyuren, which closed up by 3.51% with a turnover rate of 23.24% and a transaction amount of 368 million yuan [3] - Other notable stocks included Aerospace Nanhu, which rose by 5.00% with a turnover rate of 20.06%, and Suochen Technology, which had a turnover rate of 19.66% [3] Sector Analysis - In terms of sector performance, the pharmaceutical and biotechnology sector had the most stocks with a turnover rate exceeding 5%, totaling 32 stocks, followed by the computer and electronics sectors with 18 and 7 stocks, respectively [2] - Among the high turnover stocks, 58 stocks rose today, with Fumiao Technology, Olin Biology, and DeMa Technology leading with increases of 20.02%, 18.93%, and 14.74%, respectively [2] Capital Flow - In terms of capital flow, 48 stocks with high turnover rates saw net inflows from main funds, with the highest net inflows recorded for Youkede, Kaiyin Technology, and Rongchang Biology, amounting to 104 million yuan, 9.403 million yuan, and 6.991 million yuan, respectively [2] - Conversely, the stocks with the largest net outflows included Guokexingong, Maiwei Biology, and Jiayuan Technology, with net outflows of 239 million yuan, 16.9 million yuan, and 13.4 million yuan, respectively [2] Leverage Fund Movements - A total of 51 stocks with high turnover rates recently received net purchases from leveraged funds, with notable increases in financing balances for Gaoce Shares, Shijia Photon, and Weixin Biology, which saw increases of 72.986 million yuan, 71.531 million yuan, and 71.373 million yuan, respectively [2]

Summary of Key Points Core Viewpoint - The resignation of Mr. Wang Yifeng, the Vice General Manager of Beijing Qingyun Technology Group Co., Ltd., is due to personal reasons, and it will not affect the company's normal operations and management [1][2]. Group 1: Management Changes - Mr. Wang Yifeng submitted his resignation on July 16, 2025, and will no longer hold any position within the company after his resignation [1]. - The resignation is effective immediately upon the board's receipt of the resignation report, and Mr. Wang has completed the necessary work handover [1]. - Mr. Wang did not directly hold any shares in the company and held shares indirectly through partnerships [1]. Group 2: Company Impact - The company confirms that Mr. Wang's departure will not impact its normal operations and management [1]. - The board expresses gratitude for Mr. Wang's contributions during his tenure [2].

重要内容提示： 北京青云科技集团股份有限公司（以下简称"公司"）董事会于 2025 年 7 月 16 日收到副总经理王义峰先生的书面辞职报告，因个人原因，王义峰先生向 公司董事会申请辞去公司副总经理职务，辞职后，王义峰先生将不再担任公司任 何职务。 证券代码：688316 证券简称：青云科技 公告编号：2025-033 北京青云科技集团股份有限公司 关于公司副总经理离任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、高级管理人员离任情况 | 姓名 | 离任职务 | 离任时间 | | 原定任期到期 | 离任原因 | 是否继续在上 市公司及其控 | 是否存在未 履行完毕的 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | 日 | | 股子公司任职 | 公开承诺 | | 王义峰 | 副总经理 | 2025 年 7 | 月 | 第二届董事会 | 个人原因 | 否 | 是 | | | | 日 16 | | 任期届满之日 | | | | (一)提前离任的 ...

证券代码：688316 证券简称：青云科技 公告编号：2025-032 北京青云科技集团股份有限公司 一、独立董事离任情况 (一)提前离任的基本情况 | | | | 原定任期 | | 是否继续在上 | 是否存在未 | | --- | --- | --- | --- | --- | --- | --- | | 姓名 | 离任职务 | 离任时间 | 到期日 | 离任原因 | 市公司及其控 | 履行完毕的 | | | | | | | 股子公司任职 | 公开承诺 | | | 独立董事、提名委员 会委员、战略委员会 | 公司股东会选 | 第二届董 | 连续担任 独立董事 | 否 | | | 李星 | 委员、薪酬与考核委 | 举产生新任独 | 事会任期 | | | 否 | | | | 立董事之日 | 届满之日 | 满六年 | | | | | 员会委员 | | | | | | (二)离任对公司的影响 关于公司独立董事任期届满离任的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 北京青云科技集团股份有限公司（以下简称"公 ...

Group 1 - The Shanghai Stock Exchange has released the "Self-Regulatory Supervision Guidelines for Companies Listed on the Sci-Tech Innovation Board No. 5 - Sci-Tech Growth Tier" [1] - The reform does not impose additional listing thresholds for unprofitable companies entering the Sci-Tech Growth Tier, allowing 32 existing unprofitable companies to enter immediately upon the guideline's implementation [1] - Newly registered unprofitable companies will enter the Sci-Tech Growth Tier from the date of their listing [1] Group 2 - Investors participating in the subscription and trading of newly registered stocks in the Sci-Tech Growth Tier must sign a "Risk Disclosure Statement for the Sci-Tech Growth Tier" [2] - The 32 existing companies that have not yet removed the "U" designation include: Zejing Pharmaceutical, Junshi Biosciences, Frontier Biotech, Qingyun Technology, Hehui Optoelectronics, Jingjin Electric, BeiGene, Dize Pharmaceutical, Maiwei Biotech, Aojie Technology, Yuhong Pharmaceutical, Shouyao Holdings, Haichuang Pharmaceutical, CloudWalk Technology, Yifang Biotech, Obsidian Optics, Mengke Pharmaceutical, Nuo Cheng Jianhua, Xinke Mobile, Xinghuan Technology, Yutai Micro, Yuntian Lifa, Tianzhihang, Qi Anxin, Hanwujin, Yihua Tong, Aifute, Huizhiwei, Xinlian Integrated, Zhixiang Jintai, Shengke Communication, and Zhongjuxin [2]

Core Viewpoint - The company has decided to cancel a total of 168,384 shares of unvested restricted stock due to various reasons including employee departures and performance evaluations [6][7][8]. Group 1: Decision Process and Disclosure - The company held its second board meeting on June 27, 2025, where it approved the proposal to cancel certain unvested restricted stocks [1]. - The supervisory board also reviewed and verified the related proposals regarding the restricted stock incentive plan [2][3]. - Independent directors provided their opinions on the proposals, affirming the legitimacy of the conditions for the initial grant [4][5]. Group 2: Specifics of the Canceled Restricted Stocks - The cancellation includes 66,215 shares from 16 individuals who left the company, 57,225 shares from 13 individuals who did not meet performance criteria, 38,977 shares from 12 individuals who left, and 2,690 shares from 8 individuals with partial performance issues [6][7]. - Additionally, 3,277 shares were canceled due to voluntary forfeiture by 2 individuals [7]. Group 3: Impact on the Company - The cancellation of these restricted stocks is not expected to have a significant impact on the company's financial status or operational results [7]. - The stability of the management team and the ongoing implementation of the stock incentive plan will remain unaffected [7]. Group 4: Committee and Legal Opinions - The Compensation and Assessment Committee supported the cancellation, stating that the reasons for the cancellation align with legal and regulatory requirements [8]. - Legal opinions confirm that the company has obtained necessary approvals and that the actions taken comply with relevant laws and regulations [9].

北京青云科技集团股份有限公司董事会薪酬与考核委员会 关于公司 2021 年限制性股票激励计划首次授予部分第三个 归属期及预留授予部分第二个归属期归属名单的核查意见 北京青云科技集团股份有限公司（以下简称"公司"）董事会薪酬与考核委 员会依据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国 证券法》（以下简称"《证券法》"）、《上市公司股权激励管理办法》（以下简称"《管 理办法》"）、《上海证券交易所科创板股票上市规则》（以下简称"《上市规则》"）、 《科创板上市公司自律监管指南第 4 号——股权激励信息披露》等相关法律、法 规、规范性文件和《北京青云科技集团股份有限公司章程》（以下简称"《公司章 程》"）的有关规定，对本次限制性股票激励计划首次授予部分第三个归属期及预 留授予部分第二个归属期符合归属条件的激励对象名单进行核查，发表核查意见 如下： 董事会薪酬与考核委员会 2025 年 6 月 27 日 （以下无正文） 北京青云科技集团股份有限公司 经核查，本次拟归属的 52 名激励对象绩效考核结果合规、真实，不存在虚 假、故意隐瞒等相关情况，符合《公司法》《证券法》等法律、法规和规范性文 ...

证券代码：688316 证券简称：青云科技 公告编号：2025-030 北京青云科技集团股份有限公司 关于 2021 年限制性股票激励计划首次授予部分 第三个归属期及预留授予部分第二个归属期 归属条件成就的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、股权激励计划批准及实施情况 （一）本次股权激励计划的主要内容 1、股权激励方式：第二类限制性股票。 2、授予数量：《北京青云科技股份有限公司 2021 年限制性股票激励计划（草 案）》（以下简称"本激励计划"）拟授予的限制性股票数量 177.9831 万股， 占本激励计划草案公告时公司股本总额 4746.2175 万股的 3.75%。其中，首次授 予 142.3865 万股，占本激励计划公告时公司股本总额的 3.00%，占本次授予权益 总额的 80.00%；预留 35.5966 万股，占本激励计划公告时公司股本总额的 0.75%， 预留部分占本次授予权益总额的 20.00%。 3、授予价格：31.85 元/股。 本激励计划首次授予的限制性股票的归属 ...

证券代码：688316 证券简称：青云科技 公告编号：2025-031 北京青云科技集团股份有限公司 关于作废部分已授予尚未归属的限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 北京青云科技集团股份有限公司（以下简称"公司"）于 2025 年 6 月 27 日召开的第二届董事会第二十八次会议，审议通过了《关于作废部分已授予尚未 归属的限制性股票的议案》，现将相关事项公告如下： 一、本次限制性股票授予已履行的决策程序和信息披露情况 1、2021 年 10 月 26 日，公司召开第一届董事会第十八次会议，会议审议通 过了《关于<北京青云科技股份有限公司 2021 年限制性股票激励计划（草案）> 及其摘要的议案》《关于<北京青云科技股份有限公司 2021 年限制性股票激励计 划实施考核管理办法>的议案》以及《关于提请股东大会授权董事会办理公司 2021 年限制性股票激励计划有关事项的议案》等议案。公司独立董事就《北京 青云科技股份有限公司 2021 年限制性股票激励计划（草案）》（以下简称"本 激励计划"）相关 ...

北京市盈科律师事务所 关于北京青云科技集团股份有限公司 2021 年限制性股票激励计划首次授予部分 第三个归属期及 预留授予部分第二个归属期归属条件成就 及部分限制性股票作废事项的法律意见书 北京市朝阳区金和东路 20 号院正大中心 2 号楼 19-25 层 2025 年 6 月 法律意见书 北京市盈科律师事务所关于北京青云科技集团股份有限公司 2021年限制性股票激励计划首次授予部分第三个归属期及 预留授予部分第二个归属期归属条件成就 及部分限制性股票作废事项的法律意见书 致：北京青云科技集团股份有限公司 北京市盈科律师事务所（以下简称"本所"）受北京青云科技集团股份有限 公司（以下简称"青云科技"或"公司"）委托，根据《中华人民共和国公司法》 《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股权激励 管理办法》《上海证券交易所科创板股票上市规则》《科创板上市公司自律监管 指南第 4 号——股权激励信息披露》等法律、行政法规和其他规范性文件及《北 京青云科技集团股份有限公司章程》的有关规定，就《北京青云科技股份有限公 司 2021 年限制性股票激励计划（草案）》（以下简称"《激励计划》"）所涉 ...